Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Kangji Medical Holdings Limited ( (HK:9997) ).
Kangji Medical Holdings Limited and Knight Bidco Limited have announced the satisfaction of all pre-conditions for the proposed privatization of Kangji Medical by way of a scheme of arrangement. This development marks a significant step towards the company’s delisting, pending further conditions such as court approval, which could impact its market presence and shareholder arrangements.
The most recent analyst rating on (HK:9997) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Kangji Medical Holdings Limited stock, see the HK:9997 Stock Forecast page.
More about Kangji Medical Holdings Limited
Kangji Medical Holdings Limited is a company incorporated in the Cayman Islands, operating in the medical industry. It focuses on providing medical devices and solutions, with a market focus on healthcare innovations.
Average Trading Volume: 7,170,967
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.22B
See more insights into 9997 stock on TipRanks’ Stock Analysis page.